GERALDINA DOUGLAS: Open Payments
NPI 1598965741 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $126 |
| Stemline Therapeutics Inc. | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
Products named: AIRSUPRA, Orserdu, COBENFY.
Industry payments across CA — which companies pay providers there.
